The impact of residual renal function on the adequacy of peritoneal dialysis

Contributions to Nephrology

Volumn 124, Issue , 1998, Pages 76-102

  Lameire, N H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Adequacy of dialysis; CAPD; Residual renal function; Ultrafiltration failure

Indexed keywords

CREATININE;

CASE REPORT; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MALE; METHODOLOGY; MIDDLE AGED; MONITORING; PATHOPHYSIOLOGY; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SENSITIVITY AND SPECIFICITY; UREA NITROGEN BLOOD LEVEL; URINE;

BLOOD UREA NITROGEN; CREATININE; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROSTATECTOMY; PROSTATIC HYPERPLASIA; SENSITIVITY AND SPECIFICITY;

EID: 0032240021     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059932     Document Type: Article

References (99)

1. Port FK, Held PJ, Nolph KD, et al: Risk of peritonitis and technique failure by CAPD connection technique: A national study. Kidney Int 1992;42:967.
2. Viglino G, Cantaluppi A, Gandolfo C, Peluso F, Cavalli PL: Y-set evolution: in La Greca G, Ronco C, Feriani M, Chiaramonte S, Conz P (eds): Peritoneal Dialysis. Milan, Wichtig, 1991, pp 281-293.
3. Popovich RP, Moncrief JW, Decherd JF, Bomar JB, Pyle WK: The definition of a novel portable/ wearable equilibrium dialysis technique (abstract). Trans Am Soc Artif Int Organs 1976;5:64.
4. Popovich RP, Moncrief JW, Decherd JF, Pyle WK, Morris S, Lindley JD: Clinical developments of the low dialysis clearance hypothesis via equilibrium peritoneal dialysis. Proc Annual Contractors Conf Artif Kidney - Chronic Uremia Prog (NIAMDO) 1977;10:123-125.
5. Rose BD: Clinical Physiology of Acid-Base and Electrolyte Disorders, ed 4. New York, McGraw-Hill, 1994, pp 48-55.
6. Payne RB: Creatinine clearance: A redundant clinical investigation. Ann Clin Biochem 1986;23:243-250.
7. Doolan PD, Alpen EL, Theil GB: A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 1962;32:65-79.
8. Kim KE, Onesti G, Ramirez O, Brest AN, Swartz C: Creatinine clearance in renal disease. A reappraisal. Br Med J 1969;iv:11-14.
9. Levey AS: Measurement of renal function in chronic renal disease. Kidney Int 1990;38:167-184.
10. Van Acker BAC, Koomen GCM, Koopman MG, de Waart DR, Arisz L: Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet 1992;340:1326-1329.
11. Petri M, Bockenstedt L, Colman J, et al: Serial assessment of glomerular filtration rate in lupus nephropathy. Kidney Int 1988;34:832-839.
12. 99mTc-DTPA, and inulin. Am J Kidney Dis 1990;16:224-235.
13. Hilbrands LB, Artz MA, Wetzels JF, Koene RA: Cimetidine improves the reliability of creatinine as a marker of glomerular filtration. Kidney Int 1991;40:1171-1176.
14. Hiratadulas CAI, Halstenson CE, Kasiske BL: Improvement in the accuracy and precision of creatinine clearance as a measure of glomerular filtration rate with oral cimetidine in renal transplant recipients. Clin Transplant 1993;7:552-558.
15. Agarwal R: Creatinine clearance with cimetidine for measurement of GFR (letter). Lancet 1993;341:188.
16. Lubowitz H, Slatopolsky E, Shankel S, et al: Glomerular filtration rate determination in patients with chronic renal disease. JAMA 1967;199:252.
17. Van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with CAPD (abstract). Sixth Benelux Dial Symp, Brussels 1995.
18. Milutinovic J, Cutler RE, Hoover P, Meusen B, Scribner BH: Measurement of glomerular filtration rate in patients receiving repetitive hemodialysis. Kidney Int 1975;8:185-190.
19. Gaspari F, Perico N, Ruggenenti P, et al: Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995;6:257-263.
20. Swan SK, Halstenson CE, Kasiske BL, Collins AJ: Determination of residual renal function with iohexol clearance in hemodialysis patients. Kidney Int 1996;49:232-235.
21. Marx MA, Shuler CL, Tattersall JE, Golper TA: Plasma iohexol clearance as an alternative to creatinine clearance for CAPD adequacy studies. Kidney Int 1995;48:1994-1997.
22. Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B, Legrain M: Evolution of residual renal function in patients undergoing maintenance hemodialysis or continuous ambulatory peritoneal dialysis. Proc EDTA 1983;19:397-403.
23. Nolph KD: Is residual renal function better preserved with CAPD than with hemodialysis? Am Kidney Fund Nephrol Lett 1990;7:1-7.
24. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrel PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991;37:598-604.
25. Rottembourg J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 1993;43(suppl 40):106-110.
26. Iest CG, Vanholder RC, Ringoir SM: Loss of residual renal function in patients on regular hemodialysis. Int J Artif Organs 1989;12:154-159.
27. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A: Rapid decline of residual renal function in patients on automated peritoneal dialysis. Peril Dial Int 1996;16:307-315.
28. McCarthy JT: The use of polysulfone dialyzers slows the rate of intrinsic renal function loss in chronic hemodialysis patients (abstract). J Am Soc Nephrol 1993;4:367.
29. McKane WS, Tattersall JE, Farrington K: Preservation of residual renal function in high flux haemodialysis (abstract). Nephrol Dial Transplant 1994;9:1686.
30. Schifl H: Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients (letter). Nephrol Dial Transplant 1995;10:611-612.
31. Van Stone JC: The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J 1995;41:M713-M716.
32. Caramelo C, Alcazar R, Gallar P, et al: Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol Dial Transplant 1994;9:675-677.
33. Caro J, Brown S, Miller O, Murray TG, Erslev AJ: Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 1979;93:449-454.
34. Zappacosta AR, Caro J, Erslev A: Normalization of hematocrit in patients with end-stage renal disease on CAPD. The role of erythropoietin. Am J Med 1982;72:53-57.
35. Chandra M, Clemons GK, McVicar M, Wilkes B, Mossey RT: Serum erythropoietin levels and hematocrit in end-stage renal disease: Influence of the mode of therapy. Am J Kidney Dis 1988;12:208-213.
36. Jongen MJM, Van der Vijgh WSF, Lip P, Netelenbos JC: Measurements of vitamin D metabolites in anephric subjects. Nephrol 1984;36:230-236.
37. 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis. Clin Nephrol 1987;27:245-249.
38. Rottembourg J, Allouache M, Mussey L, Jacobs C: Beta-2-microglobulin in dialyzed patients: Hemodialysis versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1987;2:248-249.
39. Thielemans C, Dratwa M, Bergmann P, Goldman M, Flamion B, Collart F, Wens R: Continuous ambulatory peritoneal dialysis versus haemodialysis: A lesser risk of amyloidosis. Nephrol Dial Transplant 1988;3:291-294.
40. Acchiacardo S, Krau AP, Jennings BR: Beta-2-microglobulin levels in patients with renal insufficiency. Am J Kidney Dis 1989;13:70-74.
41. Scalamogna A, Imbasciati E, Devecchi A, Castelnovo C, Pagliari B, De Christofaro V, Ponticelli C: Beta-2-microglobulin in patients on peritoneal dialysis and hemodialysis. Perit Dial Int 1989;9:37-40.
42. Montenegro J, Martinez I, Saracho R, Gonzalez R: β2-Microglobulin in CAPD. Adv Peril Dial 1992;8:369-372.
43. Amici G, Virga G, Da Rin G, et al: Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis. Nephron 1993;65:469-471.
44. Tielemans C, Dratwa M, Bergmann P, et al: Continuous ambulatory peritoneal dialysis: A lesser risk of amyloidosis? Nephrol Dial Transplant 1988;3:291-294.
45. Keshaviah P: Adequacy of CAPD: A quantitative approach. Kidney Int 1992;42:(suppl 38):160-164.
46. Nolph KD, Twardowski ZJ, Keshaviah PR: Weekly clearances of urea and creatinine on CAPD and NIPD. Peril Dial Int 1992;12:298-303.
47. Churchill DN, Taylor DW, Keshaviah P: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome. J Am Soc Nephrol 1996;7:198-207.
48. Faller B, Lemeire N: Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994;9:280-286.
49. Lameire N, Vanholder R, Vijt D, Lambert MC, Ringoir S: A longitudinal five-year survey of urea kinetic parameters in CAPD patients. Kidney Int 1992;42:426-432.
50. Watson PE, Watson ID, Ball RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27-39.
51. Keshaviah P, Nolph KD: The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis and hemodialysis. Peril Dial Int 1989;9:257-260.
52. Ronco C, Conz P, Agostini F, Bosch JP, Lew SQ, La Greca G: The concept of adequacy of peritoneal dialysis. Perit Dial Int 1994;14(suppl 3):93-98.
53. Keshaviah P: Can peritoneal dialysis be equivalent to (or better than) optimal hemodialysis? Semin Dial 1996;9:243-245.
54. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC: Relationship between body size fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 1994;4:1820-1826.
55. Blake PG: Targets in CAPD and APD prescription. Perit Dial Int 1996;16:S143-S146.
56. Tattersall JE, Doyle S, Greewood RN, Farrington K: Maintaining adequacy in CAPD by individualizing the dialysis prescription. Nephrol Dial Transplant 1994;9:749-752.
57. Johnston JR, Bernardini J, Holley J, Piraino B: Effect of increasing exchange volume or frequency on CAPD efficiency (abstract). Perit Dial Int 1995;15:S41.
58. Diaz-Buxo JA, Suki WN: Automated peritoneal dialysis: in Gokal R, Nolph KD (eds): The Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic Publishers, 1994, pp 399-418.
59. De Fijter CW, Oe LP, Nauta JJ, et al: Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994;120:264-271.
60. Brunkhorst R, Wrenger F, Krautzig S, Ehlerding G, Mahiout A, Koch KM: Clinical experience with home automated peritoneal dialysis. Kidney Int 1994;46(suppl 48):25-30.
61. Twardowski Z, Nolph KD: Is peritoneal dialysis feasible once a large muscular patient becomes anuric? Peril Dial Int 1996;16:20-23.
62. Lameire N, Bernaert P, Lambert MC, Vijt D: Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1994;46(suppl 48):31-38.
63. Lameire N, Vanholder R, Van Loo A, et al: Cardiovascular diseases in peritoneal dialysis patients: The size of the problem. Kidney Int 1996;50(suppl 56):28-36.
64. Parfrey S, Harnett JD, Foley RN: Heart failure and ischemic heart disease in chronic uremia. Curr Opin Nephrol Hypertens 1995;4:105-110.
65. Amann K, Ritz E: Cardiac structure and function in renal disease. Curr Opin Nephrol Hypertens 1996;5:102-106.
66. Alpert MA, Hüting J, Twardowski ZJ, Khanna R, Nolph KD: Continuous ambulatory peritoneal dialysis and the heart. Perit Dial Int 1995;15:6-11.
67. Culleton B, Parfrey PS: Cardiovascular risk in continuous ambulatory peritoneal dialysis. Perit Dial Int 1996;16:10-12.
68. Churchill DN: Can peritoneal dialysis be equivalent to (or better than) optimal hemodialysis? Semin Dial 1996;9:240-241.
69. Gotch F, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study. Kidney Int 1985;28:526-534.
70. Keshaviah P, Ma J, Thorpe K, Churchill D, Collins A: Comparison of 2-year survival on hemodialysis and peritoneal dialysis with a dose of dialysis matched using the peak concentration hypothesis (abstract). J Am Soc Nephrol 1995;6:540.
71. Saldanha LF, Weiler E, Gonick HC: Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993;21:184-188.
72. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
73. Charra B, Calemard E, Laurent G: Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996;16:35-44.
74. Tzamaloukas AH, Saddler MC, Murata GH, et al: Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995;6:198-206.
75. Mulec H, Blohmé G, Kullenberg K, Nyberg G, Björck S: Latent overhydration and nocturnal hypertension in diabetic nephropathy. Diabetologia 1995;38:216-220.
76. Davies SJ, Bryan J, Phillips L, Russel GI: The predictive value of Kt/V and peritoneal solute transport in CAPD patients is dependent on the type of comorbidity present. Perit Dial Int 1996;16 (suppl I):158-162.
77. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990;38:495-506.
78. Selgas R, Fedez-Reyes MJ, Bosque E, et al: Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994;23:64-73.
79. Selgas R, Bajo MA, Del Peso G, Jimenez C: Preserving the peritoneal membrane in long-term peritoneal dialysis patients. Semin Dial 1995;8:326-332.
80. Fliser D, Schröder M, Neubeck M, Ritz E: Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994;46:482-488.
81. Scarpioni L, Ballochi S, Bergonzi G, Fontana F, Poisetti P, Zanazzi MA: High dose diuretics in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982;2:177-178.
82. Grantham JJ, Chonko AM: The physiologic basis and clinical use of diuretics; in Brenner BM, Stein JH (eds): Contemporary Issues in Nephrology: Sodium and Water Homeostasis. New York, Churchill Livingstone, 1978, pp 178-211.
83. Schulman G, Hakim RM: Improving outcomes in chronic hemodialysis patients: Should dialysis be initiated earlier? Semin Dial 1996;9:225-229.
84. Bonomini V, Feletti C, Scolari MP, Stefoni S: Early dialysis. Contrib Nephrol. Basel, Karger, 1984, vol 37, pp 45-51.
85. Bonomini V: Timing dialysis in chronic uraemic. Life Support Syst 1987;5:1-7.
86. Tattersall J, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 1995;15:283-289.
87. Blumenkrantz MJ, Wolfson M, Kopple J: Nutritional status of patients on hemodialysis. Am J Nutr 1980;33:1567-1588.
88. Burkart JM, Nolph KD: Peritoneal dialysis; in Brenner BM (ed): The Kidney, ed 5. Philadelphia, Saunders, 1996, pp 2507-2575.
89. Churchill DN: Indications for long-term results and limitations of peritoneal dialysis; in Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds): Replacement of Renal Function by Dialysis, ed 4. Dordrecht, Kluwer Academic Publishers, 1996, pp 603-618.
90. Wong KC, Xiong DW, Kerr PG, et al: Kt/V in CAPD by different estimations of V. Kidney Int 1995;48:563-569.
91. Tzamaloukas AH: Effect of edema on urea kinetics in peritoneal dialysis patients. Perit Dial Int 1994;14:398-401.
92. Lameire N, Matthys D, Matthys E, Beheydt R: Effects of long-term CAPD on carbohydrate and lipid metabolism. Clin Nephrol 1988;30(suppl 1):53-58.
93. Blake PG: Do mortality rates differ between hemodialysis and CAPD? A look at the Canadian vs. US data. Dial Transplant 1996;25:75-100.
94. Wieslander AP, Deppisch R, Svensson E, Forsbäck G, Speidel R, Ripple B: In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Peril Dial Int 1995;15:158-164.
95. 3 modulate peritoneal macrophage antimicrobial activity in CAPD patients. Adv Perit Dial 1990;6:110-113.
96. Piraino B, Bernardini J, Holley JL, Perlmutter JA: Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/calcium. Am J Kidney Dis 1992;19:371-374.
97. Hutchison A, Turner K, Gokal R: Effect of long-term therapy with 1.25 mmol/l calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPD. Perit Dial Int 1992;12:321-325.
98. Weinreich T, Passlick-Deetjen J, Ritz E: Low dialysate calcium in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1995;25:452-460.
99. Weinreich T: Low or high calcium dialysate solutions in peritoneal dialysis? Kidney Int 1996;50(suppl 56):92-96.